[Effectiveness of prolonged oral administration of low-dose etoposide in a case of malignant lymphoma in the mesenterium].
Malignant lymphoma in the mesenterium is rare and carries a poor prognosis, although curative resection cases have been reported. A 39-year-old woman with non-resectable mesenteric malignant lymphoma obtained a better QOL and outcome from prolonged oral administration of low-dose etoposide as a maintenance therapy after CHOP therapy.
Sato
Tadao
T
Dept. of Surgery, Yokohama Seamens' Insurance Hospital.
Yanagihara
Masatomo
M
Sato
Kaori
K
Nozawa
Tadashi
T
Furukawa
Yusuke
Y
Imanishi
Hiroaki
H
Kouzuma
Tatuya
T
D000284:Administration, Oral; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide; D004317:Doxorubicin; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008643:Mesentery; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D011239:Prednisolone; D014750:Vincristine
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone